 | | Register Early & Maximize Your Savings – Best Rates Now Available! Take advantage of early discounts or use the generous team discount to allow more members of your lab group to attend at a reduced rate. | |
 |
Now entering its eighth year, IBC's Formulation Strategies for Protein Therapeutics is a must-attend conference each year for formulation, delivery and analytical development scientists from biotherapeutic development organizations from around the world.
- Understand how to optimize formulations for pre-filled syringe products from early development to commercialization with strategies from Amgen, Biogen-Idec, Human Genome Sciences, Merck, West Pharmaceutical Services and the U.S. Food and Drug Administration
- Learn how to design quality into your protein therapeutics from the start in an important panel, "The QbD Pioneers: Perspectives from Companies that have Implemented Quality by Design Concepts in Formulation Development"
- Overcome the challenges of formulating high concentration proteins – with case studies from Abbott Laboratories, Amgen, Genentech, Roche and Wyeth
- Benchmark your formulation operation in a facilitated small group Best Practices Exchange for formulation scientists
The topics presented in this meeting are determined through the input of formulation scientists like you who are also trying to overcome the challenges of advanced protein therapeutics and next-generation delivery methods.
2008 program highlights:
- 20 industry case studies - showing you how colleagues from other companies deal with the day-to-day challenges of formulating novel protein drug products
- Extended Case Study - tracking the path of a protein formulation from early development through commercial development
- IBC's facilitated Scientific Exchange discussions - giving you the opportunity to talk with formulation colleagues from other organizations in a small group setting
- Sessions on the most important aspects of formulation development - resolving stability problems, measuring and minimizing aggregation, lyophilization development and working with predictive analytical methods
- Tracking the evolution of high concentration proteins in a new set of case study presentations from companies advancing these programs through development
- A special presentation on the role of formulation development in biologics patent protection - helping you understand how to confront the emerging world of biosimilars
And, because Formulation Strategies is co-located with the BioProcess International™ Conference and Exhibition, you will have the opportunity to visit with more than 120 suppliers of bioprocess technology and services and network with over 1,500 industry leaders in attendance. The Disney Resort location ensures you plenty of nighttime entertainment options in walking distance and ease of transportation from major airports to the meeting.